About Technology Issues FAQ

Links

Concomitant or delayed anti-TNF differentially impact on immune-related adverse events and antitumor efficacy after anti-CD40 therapy

Concomitant or delayed anti-TNF differentially impact on immune-related adverse events and antitumor efficacy after anti-CD40 therapy — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.